PRagMatic Pediatric Trial of Balanced vs nOrmaL Saline FlUid in Sepsis: study protocol for the PRoMPT BOLUS randomized interventional trial

Scott L Weiss, Fran Balamuth, Elliot Long, Graham C Thompson, Katie L Hayes, Hannah Katcoff, Marlena Cook, Elena Tsemberis, Christopher P Hickey, Amanda Williams, Sarah Williamson-Urquhart, Meredith L Borland, Stuart R Dalziel, Ben Gelbart, Stephen B Freedman, Franz E Babl, Jing Huang, Nathan Kuppermann, Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis (PRoMPT BOLUS) Investigators of the PECARN, PERC, and PREDICT Networks, E Long, A Williams, F Babl, M Borland, S O'Brien, S Craig, E Ramaga, A Kochar, G Nivea, S Jani, D Thosar, A Rao, N Phillips, S George, A Lithgow, C Mitchell, G Thompson, S Freedman, S Williamson-Urquhart, E Gilad, S Cooke, P Judge, S Murthy, N Kissoon, W Alqurashi, F Alnaji, G Sangha, A Mater, M Brashaw, S Curtis, A Joffe, Y Shayan, M Tucci, K Gripp, S Berthelot, M Weiss, A Davis, E Guifoyle, M Moretti, A Kam, M Parker, B Rochwerg, J Emsley, N Verma, A Sehgal, S Dalziel, M Bonisch, E Tan, J Neutze, F Balamuth, S Weiss, E Tsemberis, J Huang, M Cook, H Katcoff, K Hayes, C Hickey, M Eisenberg, D Lewander, C Morris, D Hurley, S Baumer-Mouradian, L Ambroggio, K Grice, A Festekjian, B Hickey, R Sada, J Dodson, M Badawy, C Lebel, M Elliott, I Koutralis, K Hom, M Eckerle, M Singleton, A Rogers, V Cervantes, S Duffy, I Bahamon, L Alpern, A Sirizi, A Haider Ahmad, A Rubi Banegas, J Lloyd, K DiCostanzo, M Kwok, J Ochs, R Lane, T Harbour, N Uspal, K Cappetto, L Clukies, D Robinsonm, J McManemy, V Gonzales, C Vance, N Kupperman, K Pimenta, K Mansour, L Lavrisha, M Ramirez, J Grad, Scott L Weiss, Fran Balamuth, Elliot Long, Graham C Thompson, Katie L Hayes, Hannah Katcoff, Marlena Cook, Elena Tsemberis, Christopher P Hickey, Amanda Williams, Sarah Williamson-Urquhart, Meredith L Borland, Stuart R Dalziel, Ben Gelbart, Stephen B Freedman, Franz E Babl, Jing Huang, Nathan Kuppermann, Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis (PRoMPT BOLUS) Investigators of the PECARN, PERC, and PREDICT Networks, E Long, A Williams, F Babl, M Borland, S O'Brien, S Craig, E Ramaga, A Kochar, G Nivea, S Jani, D Thosar, A Rao, N Phillips, S George, A Lithgow, C Mitchell, G Thompson, S Freedman, S Williamson-Urquhart, E Gilad, S Cooke, P Judge, S Murthy, N Kissoon, W Alqurashi, F Alnaji, G Sangha, A Mater, M Brashaw, S Curtis, A Joffe, Y Shayan, M Tucci, K Gripp, S Berthelot, M Weiss, A Davis, E Guifoyle, M Moretti, A Kam, M Parker, B Rochwerg, J Emsley, N Verma, A Sehgal, S Dalziel, M Bonisch, E Tan, J Neutze, F Balamuth, S Weiss, E Tsemberis, J Huang, M Cook, H Katcoff, K Hayes, C Hickey, M Eisenberg, D Lewander, C Morris, D Hurley, S Baumer-Mouradian, L Ambroggio, K Grice, A Festekjian, B Hickey, R Sada, J Dodson, M Badawy, C Lebel, M Elliott, I Koutralis, K Hom, M Eckerle, M Singleton, A Rogers, V Cervantes, S Duffy, I Bahamon, L Alpern, A Sirizi, A Haider Ahmad, A Rubi Banegas, J Lloyd, K DiCostanzo, M Kwok, J Ochs, R Lane, T Harbour, N Uspal, K Cappetto, L Clukies, D Robinsonm, J McManemy, V Gonzales, C Vance, N Kupperman, K Pimenta, K Mansour, L Lavrisha, M Ramirez, J Grad

Abstract

Background/aims: Despite evidence that preferential use of balanced/buffered fluids may improve outcomes compared with chloride-rich 0.9% saline, saline remains the most commonly used fluid for children with septic shock. We aim to determine if resuscitation with balanced/buffered fluids as part of usual care will improve outcomes, in part through reduced kidney injury and without an increase in adverse effects, compared to 0.9% saline for children with septic shock.

Methods: The Pragmatic Pediatric Trial of Balanced versus Normal Saline Fluid in Sepsis (PRoMPT BOLUS) study is an international, open-label pragmatic interventional trial being conducted at > 40 sites in the USA, Canada, and Australia/New Zealand starting on August 25, 2020, and continuing for 5 years. Children > 6 months to < 18 years treated for suspected septic shock with abnormal perfusion in an emergency department will be randomized to receive either balanced/buffered crystalloids (intervention) or 0.9% saline (control) for initial resuscitation and maintenance fluids for up to 48 h. Eligible patients are enrolled and randomized using serially numbered, opaque envelopes concurrent with clinical care. Given the life-threatening nature of septic shock and narrow therapeutic window to start fluid resuscitation, patients may be enrolled under "exception from informed consent" in the USA or "deferred consent" in Canada and Australia/New Zealand. Other than fluid type, all decisions about timing, volume, and rate of fluid administration remain at the discretion of the treating clinicians. For pragmatic reasons, clinicians will not be blinded to study fluid type. Anticipated enrollment is 8800 patients. The primary outcome will be major adverse kidney events within 30 days (MAKE30), a composite of death, renal replacement therapy, and persistent kidney dysfunction. Additional effectiveness, safety, and biologic outcomes will also be analyzed.

Discussion: PRoMPT BOLUS will provide high-quality evidence for the comparative effectiveness of buffered/balanced crystalloids versus 0.9% saline for the initial fluid management of children with suspected septic shock in emergency settings.

Trial registration: PRoMPT BOLUS was first registered at ClinicalTrials.gov ( NCT04102371 ) on September 25, 2019. Enrollment started on August 25, 2020.

Keywords: Crystalloid; Intravenous fluid; Pediatric; Pragmatic trial; Renal failure; Saline; Sepsis; Septic shock.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2021. The Author(s).

Figures

Fig. 1
Fig. 1
Schematic overview of the study design
Fig. 2
Fig. 2
SPIRIT summary of study activities
Fig. 3
Fig. 3
Flow diagram of patients progressing through the trial

References

    1. Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, Fleischmann-Struzek C, Machado FR, Reinhart KK, Rowan K, Seymour CW, Watson RS, West TE, Marinho F, Hay SI, Lozano R, Lopez AD, Angus DC, Murray CJL, Naghavi M. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200–211. doi: 10.1016/S0140-6736(19)32989-7.
    1. Karakala N, Raghunathan K, Shaw AD. Intravenous fluids in sepsis: what to use and what to avoid. Curr Opin Crit Care. 2013;19(6):537–543. doi: 10.1097/MCC.0000000000000028.
    1. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med. 2013;369(13):1243–1251. doi: 10.1056/NEJMra1208627.
    1. Annane D, Siami S, Jaber S, Martin C, Elatrous S, Declere AD, et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA. 2013;310(17):1809–17. doi: 10.1001/jama.2013.280502.
    1. Raghunathan K, Shaw A, Nathanson B, Sturmer T, Brookhart A, Stefan MS, et al. Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis*. Crit Care Med. 2014;42(7):1585–1591. doi: 10.1097/CCM.0000000000000305.
    1. Rochwerg B, Alhazzani W, Gibson A, Ribic CM, Sindi A, Heels-Ansdell D, et al. Fluid type and the use of renal replacement therapy in sepsis: a systematic review and network meta-analysis. Intensive Care Med. 2015;41(9):1561–1571. doi: 10.1007/s00134-015-3794-1.
    1. Rochwerg B, Alhazzani W, Sindi A, Heels-Ansdell D, Thabane L, Fox-Robichaud A, Mbuagbaw L, Szczeklik W, Alshamsi F, Altayyar S, Ip WC, Li G, Wang M, Wludarczyk A, Zhou Q, Guyatt GH, Cook DJ, Jaeschke R, Annane D, Fluids in Sepsis and Septic Shock Group Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med. 2014;161(5):347–355. doi: 10.7326/M14-0178.
    1. Shaw AD, Bagshaw SM, Goldstein SL, Scherer LA, Duan M, Schermer CR, Kellum JA. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg. 2012;255(5):821–829. doi: 10.1097/SLA.0b013e31825074f5.
    1. Young JB, Utter GH, Schermer CR, Galante JM, Phan HH, Yang Y, Anderson BA, Scherer LA. Saline versus Plasma-Lyte A in initial resuscitation of trauma patients: a randomized trial. Ann Surg. 2014;259(2):255–262. doi: 10.1097/SLA.0b013e318295feba.
    1. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012;308(15):1566–1572. doi: 10.1001/jama.2012.13356.
    1. Sharma A, Yadav M, Kumar BR, Lakshman PS, Iyenger R, Ramchandran G. A comparative study of Sterofundin and Ringer lactate based infusion protocol in scoliosis correction surgery. Anesth Essays Res. 2016;10(3):532–537. doi: 10.4103/0259-1162.181425.
    1. Young P, Bailey M, Beasley R, Henderson S, Mackle D, McArthur C, McGuinness S, Mehrtens J, Myburgh J, Psirides A, Reddy S, Bellomo R, SPLIT Investigators. ANZICS CTG Effect of a Buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit: The SPLIT Randomized Clinical Trial. JAMA. 2015;314(16):1701–1710. doi: 10.1001/jama.2015.12334.
    1. Ngo NT, Cao XT, Kneen R, Wills B, Nguyen VM, Nguyen TQ, et al. Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour. Clin Infect Dis. 2001;32(2):204–213. doi: 10.1086/318479.
    1. Awad S, Allison SP, Lobo DN. The history of 0.9% saline. Clin Nutr. 2008;27(2):179–188. doi: 10.1016/j.clnu.2008.01.008.
    1. Long E, Babl F, Dalziel S, Dalton S, Etheridge C, Duke T, Paediatric Research in Emergency Departments International Collaborative (PREDICT) Fluid resuscitation for paediatric sepsis: A survey of senior emergency physicians in Australia and New Zealand. Emerg Med Australas. 2015;27(3):245–250. doi: 10.1111/1742-6723.12400.
    1. Thompson GC, Macias CG. Recognition and Management of Sepsis in Children: Practice Patterns in the Emergency Department. J Emerg Med. 2015;49(4):391–399. doi: 10.1016/j.jemermed.2015.03.012.
    1. Semler MW, Self WH, Wanderer JP, Ehrenfeld JM, Wang L, Byrne DW, Stollings JL, Kumar AB, Hughes CG, Hernandez A, Guillamondegui OD, May AK, Weavind L, Casey JD, Siew ED, Shaw AD, Bernard GR, Rice TW, SMART Investigators and the Pragmatic Critical Care Research Group Balanced Crystalloids versus Saline in Critically Ill Adults. N Engl J Med. 2018;378(9):829–839. doi: 10.1056/NEJMoa1711584.
    1. Self WH, Semler MW, Wanderer JP, Wang L, Byrne DW, Collins SP, Slovis CM, Lindsell CJ, Ehrenfeld JM, Siew ED, Shaw AD, Bernard GR, Rice TW, SALT-ED Investigators Balanced Crystalloids versus Saline in Noncritically Ill Adults. N Engl J Med. 2018;378(9):819–828. doi: 10.1056/NEJMoa1711586.
    1. Emrath ET, Fortenberry JD, Travers C, McCracken CE, Hebbar KB. Resuscitation With Balanced Fluids Is Associated With Improved Survival in Pediatric Severe Sepsis. Crit Care Med. 2017;45(7):1177–1183. doi: 10.1097/CCM.0000000000002365.
    1. Weiss SL, Keele L, Balamuth F, Vendetti N, Ross R, Fitzgerald JC, Gerber JS. Crystalloid Fluid Choice and Clinical Outcomes in Pediatric Sepsis: A Matched Retrospective Cohort Study. J Pediatr. 2017;182:304–310. doi: 10.1016/j.jpeds.2016.11.075.
    1. Weiss SL, Peters MJ, Alhazzani W, Agus MSD, Flori HR, Inwald DP, Nadel S, Schlapbach LJ, Tasker RC, Argent AC, Brierley J, Carcillo J, Carrol ED, Carroll CL, Cheifetz IM, Choong K, Cies JJ, Cruz AT, de Luca D, Deep A, Faust SN, de Oliveira CF, Hall MW, Ishimine P, Javouhey E, Joosten KFM, Joshi P, Karam O, Kneyber MCJ, Lemson J, MacLaren G, Mehta NM, Møller MH, Newth CJL, Nguyen TC, Nishisaki A, Nunnally ME, Parker MM, Paul RM, Randolph AG, Ranjit S, Romer LH, Scott HF, Tume LN, Verger JT, Williams EA, Wolf J, Wong HR, Zimmerman JJ, Kissoon N, Tissieres P. Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children. Pediatr Crit Care Med. 2020;21(2):e52–e106. doi: 10.1097/PCC.0000000000002198.
    1. Weiss SL, Peters MJ, Alhazzani W, Agus MSD, Flori HR, Inwald DP, Nadel S, Schlapbach LJ, Tasker RC, Argent AC, Brierley J, Carcillo J, Carrol ED, Carroll CL, Cheifetz IM, Choong K, Cies JJ, Cruz AT, de Luca D, Deep A, Faust SN, de Oliveira CF, Hall MW, Ishimine P, Javouhey E, Joosten KFM, Joshi P, Karam O, Kneyber MCJ, Lemson J, MacLaren G, Mehta NM, Møller MH, Newth CJL, Nguyen TC, Nishisaki A, Nunnally ME, Parker MM, Paul RM, Randolph AG, Ranjit S, Romer LH, Scott HF, Tume LN, Verger JT, Williams EA, Wolf J, Wong HR, Zimmerman JJ, Kissoon N, Tissieres P. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med. 2020;46(Suppl 1):10–67. doi: 10.1007/s00134-019-05878-6.
    1. Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, Oxman AD, Moher D, CONSORT group. Pragmatic Trials in Healthcare (Practihc) group Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008;337(nov11 2):a2390. doi: 10.1136/bmj.a2390.
    1. Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, Tunis S, Bergel E, Harvey I, Magid DJ, Chalkidou K. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol. 2009;62(5):464–475. doi: 10.1016/j.jclinepi.2008.12.011.
    1. Balamuth F, Kittick M, McBride P, Woodford A, Vestal N, Casper TC, et al. Pragmatic pediatric trial of balanced versus normal saline fluid in sepsis: the PRoMPT BOLUS pilot feasibility study. Acad Emerg Med. 2019;26(12):1346–1356. doi: 10.1111/acem.13815.
    1. Watters D, Sayre MR, Silbergleit R. Research conditions that qualify for emergency exception from informed consent. Acad Emerg Med. 2005;12(11):1040–1044. doi: 10.1197/j.aem.2005.06.022.
    1. Menon K, O'Hearn K, McNally JD, Acharya A, Wong HR, Lawson M, et al. Comparison of Consent Models in a Randomized Trial of Corticosteroids in Pediatric Septic Shock. Pediatr Crit Care Med. 2017;18(11):1009–1018. doi: 10.1097/PCC.0000000000001301.
    1. The National Health and Medical Research Council tARCaUA. National Statement on Ethical Conduct in Human Research Commonwealth of Australia, Canberra2007 (updated 2018) [Available from: .
    1. Baren JM, Fish SS. Resuscitation research involving vulnerable populations: are additional protections needed for emergency exception from informed consent? Acad Emerg Med. 2005;12(11):1071–1077. doi: 10.1197/j.aem.2005.06.020.
    1. Chamberlain JM, Okada P, Holsti M, Mahajan P, Brown KM, Vance C, Gonzalez V, Lichenstein R, Stanley R, Brousseau DC, Grubenhoff J, Zemek R, Johnson DW, Clemons TE, Baren J, Pediatric Emergency Care Applied Research Network (PECARN) Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial. JAMA. 2014;311(16):1652–1660. doi: 10.1001/jama.2014.2625.
    1. Inwald DP, Canter R, Woolfall K, Mouncey P, Zenasni Z, O'Hara C, et al. Restricted fluid bolus volume in early septic shock: results of the Fluids in Shock pilot trial. Arch Dis Child. 2018;104(5):426–431. doi: 10.1136/archdischild-2018-314924.
    1. Dalziel SR, Borland ML, Furyk J, Bonisch M, Neutze J, Donath S, Francis KL, Sharpe C, Harvey AS, Davidson A, Craig S, Phillips N, George S, Rao A, Cheng N, Zhang M, Kochar A, Brabyn C, Oakley E, Babl FE. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial. Lancet. 2019;393(10186):2135–2145. doi: 10.1016/S0140-6736(19)30722-6.
    1. Haggins AN, Harney D, Scott S, Silbergleit R. A systematic review of Federal Drug Administration Docket for community consultation and public disclosure in exception from informed consent trials. Clin Trials. 2018;15(1):29–35. doi: 10.1177/1740774517737318.
    1. Harvin JA, Podbielski JM, Vincent LE, Liang MK, Kao LS, Wade CE, Holcomb JB. Impact of Social Media on Community Consultation in Exception From Informed Consent Clinical Trials. J Surg Res. 2019;234:65–71. doi: 10.1016/j.jss.2018.09.007.
    1. Van Regenmortel N, Verbrugghe W, Roelant E, Van den Wyngaert T, Jorens PG. Maintenance fluid therapy and fluid creep impose more significant fluid, sodium, and chloride burdens than resuscitation fluids in critically ill patients: a retrospective study in a tertiary mixed ICU population. Intensive Care Med. 2018;44(4):409–417. doi: 10.1007/s00134-018-5147-3.
    1. Feld LG, Neuspiel DR, Foster BA, Leu MG, Garber MD, Austin K, et al. Clinical Practice Guideline: Maintenance Intravenous Fluids in Children. Pediatrics. 2018;142(6)
    1. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381. doi: 10.1016/j.jbi.2008.08.010.
    1. Billings FT, Shaw AD. Clinical trial endpoints in acute kidney injury. Nephron Clin Pract. 2014;127(1-4):89–93. doi: 10.1159/000363725.
    1. Weiss SL, Balamuth F, Thurm CW, Downes KJ, Fitzgerald JC, Laskin BL. Major Adverse Kidney Events in Pediatric Sepsis. Clin J Am Soc Nephrol. 2019;14(5):664–672. doi: 10.2215/CJN.12201018.
    1. Palevsky PM, Molitoris BA, Okusa MD, Levin A, Waikar SS, Wald R, Chertow GM, Murray PT, Parikh CR, Shaw AD, Go AS, Faubel SG, Kellum JA, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene T, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA. Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol. 2012;7(5):844–850. doi: 10.2215/CJN.12791211.
    1. Lan KK, Simon R, Halperin M. Stochastically curtailed tests in long-term clinical trials. Commun Stat Sequential Anal. 1982;C1:207–219.
    1. Benjamini Y, Cohen R. Weighted false discovery rate controlling procedures for clinical trials. Biostatistics. 2017;18(1):91–104. doi: 10.1093/biostatistics/kxw030.
    1. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001;125(1-2):279–284. doi: 10.1016/S0166-4328(01)00297-2.
    1. Dunn G, Maracy M, Tomenson B. Estimating treatment effects from randomized clinical trials with noncompliance and loss to follow-up: the role of instrumental variable methods. Stat Methods Med Res. 2005;14(4):369–395. doi: 10.1191/0962280205sm403oa.
    1. Breslow NE, Day NE. Statistical methods in cancer research. Volume I - The analysis of case-control studies. IARC Sci Publ. 1980;32:5–338.
    1. Wooldridge J. Inverse probability weighted estimation for general missing data problems. J Econometrics. 2007;141(2):1281–1301. doi: 10.1016/j.jeconom.2007.02.002.
    1. Horvitz DG, Thompson DJ. A generalization of sampling without replacement from a finite universe. J Am Stat Assoc. 1952;47(260):663–685. doi: 10.1080/01621459.1952.10483446.
    1. Patsopoulos NA. A pragmatic view on pragmatic trials. Dialogues Clin Neurosci. 2011;13(2):217–224. doi: 10.31887/DCNS.2011.13.2/npatsopoulos.
    1. Tosh G, Soares-Weiser K, Adams CE. Pragmatic vs explanatory trials: the pragmascope tool to help measure differences in protocols of mental health randomized controlled trials. Dialogues Clin Neurosci. 2011;13(2):209–215. doi: 10.31887/DCNS.2011.13.2/gtosh.
    1. Forsythe SM, Schmidt GA. Sodium bicarbonate for the treatment of lactic acidosis. Chest. 2000;117(1):260–267. doi: 10.1378/chest.117.1.260.
    1. Jaber S, Paugam C, Futier E, Lefrant JY, Lasocki S, Lescot T, Pottecher J, Demoule A, Ferrandière M, Asehnoune K, Dellamonica J, Velly L, Abback PS, de Jong A, Brunot V, Belafia F, Roquilly A, Chanques G, Muller L, Constantin JM, Bertet H, Klouche K, Molinari N, Jung B, Jaber S, de Jong A, Belafia F, Chanques G, Monnin M, Delay JM, Cissé M, Geniez M, Conseil M, Souche B, Paugam C, Abback PS, Futier E, Constantin JM, Lefrant JY, Muller L, Lasocki S, Lescot T, Pottecher J, Noll E, Demoule A, Morawiec E, Ferrandière M, Asehnoune K, Roquilly A, Dellamonica J, Robert A, Velly L, Triglia T, Brunot V, Molinari N, Mechati M, Arnal JM, Durand-Gasselin J, Demoly D, Hraiech S, Papazian L, Gilles V, Rimmelé T, Riu B, Cougot P, Fourcade O, Seguin P, Charbit J, Capdevila X, Leone M, Zieleskiewicz L, Ichai C, Orban JC, Darmon M, Azoulay E, Lemiale V, Zafrani L, Debbat K, Mimoz O, Guérin C, Kipnis E. Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial. Lancet. 2018;392(10141):31–40. doi: 10.1016/S0140-6736(18)31080-8.
    1. Klein L, Moore J, Biros M. A 20-year Review: The Use of Exception From Informed Consent and Waiver of Informed Consent in Emergency Research. Acad Emerg Med. 2018;25(10):1169–1177. doi: 10.1111/acem.13438.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever